Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • * [http://www.clinicaldruguse.com/ Descriptions of drugs with abnormal pharmacokinetics]
    470 bytes (59 words) - 11:09, 1 August 2008
  • ==Pharmacokinetics== Adderall XR 20 mg one daily has similar pharmacokinetics to Adderall(immediate-release) 10 mg twice dialy administered 4 hours apart
    3 KB (410 words) - 11:51, 2 February 2023
  • {{r|Pharmacokinetics}}
    274 bytes (29 words) - 14:30, 3 December 2008
  • ==Pharmacokinetics==
    2 KB (273 words) - 04:04, 3 June 2009
  • '''Pharmacokinetics''' are the "dynamic and kinetic mechanisms of exogenous chemical and drug a
    514 bytes (62 words) - 02:47, 7 October 2013
  • Auto-populated based on [[Special:WhatLinksHere/Pharmacokinetics]]. Needs checking by a human.
    520 bytes (65 words) - 19:29, 11 January 2010
  • {{r|Pharmacokinetics}}
    1 KB (138 words) - 21:03, 11 January 2010
  • ==Pharmacokinetics== ...">{{cite journal |author=Müller FO, Van Dyk M, Hundt HK, ''et al.'' |title=Pharmacokinetics of temazepam after day-time and night-time oral administration |journal=Eur
    6 KB (893 words) - 14:32, 2 February 2023
  • | title = The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibi
    2 KB (220 words) - 22:11, 20 July 2010
  • ...r the supervision of a physician. Pharmacists are often responsible for [[pharmacokinetics]], writing [[TPN]] orders, modifying warfarin therapy, managing diabetes an
    2 KB (325 words) - 21:32, 3 March 2009
  • ...hm-Based, Hybrid Machine Learning Approach to Model Selection'' Journal of Pharmacokinetics and Pharmacodynamics Springer-Netherlands pp. 196-221
    4 KB (585 words) - 13:56, 26 September 2007
  • ...gy]]- how drugs interact with biological systems. This field encompasses [[pharmacokinetics]] and [[pharmacodynamics]].
    6 KB (888 words) - 00:00, 5 March 2009
  • ...pprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093606.htm Pharmacokinetics in Patients With Impaired Renal Function—Study Design, Data Analysis, and
    7 KB (954 words) - 04:23, 12 January 2010
  • ...I, Beitelshees AL, Gaedigk A, Walker JR, Pauly DF, Eberst K et al.| title=Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy i
    7 KB (1,032 words) - 13:16, 2 February 2023
  • ...ion]]. It generally includes [[description]], [[clinical pharmacology]] ([[pharmacokinetics]], [[pharmacodynamics]]), [[clinical trial]]s, [[indication]]s and usage, [
    7 KB (973 words) - 17:35, 10 February 2024
  • * Abnormal pharmacokinetics due to ===Abnormal pharmacokinetics===
    39 KB (5,361 words) - 17:35, 10 February 2024
  • ...iomedical sciences. Areas of interest include gene therapy, cell kinetics, pharmacokinetics, chemotherapy, oncology, developmental biology, wound healing, physiology,
    10 KB (1,412 words) - 17:20, 20 October 2016
  • ...Celeste C, Vachon P, Marier JF, Plaas AH. "Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinic ...t (i.e. chloride or sulfate) is unlikely to play any role in the action or pharmacokinetics of glucosamine".<ref>[http://www.pdrhealth.com/drug_info/nmdrugprofiles/nut
    22 KB (3,050 words) - 05:38, 2 August 2011
  • ...pprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093606.htm Pharmacokinetics in Patients With Impaired Renal Function—Study Design, Data Analysis, and
    13 KB (1,800 words) - 07:59, 9 May 2012
  • ...nitial stages of treatment of status epilepticus.<ref>Treiman DM. (1989). "Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus
    13 KB (1,788 words) - 18:38, 5 May 2014
  • ==Pharmacokinetics== Because of warfarin's difficult [[pharmacokinetics]], researchers have proposed algorithms for warfarin loading.
    52 KB (7,136 words) - 22:53, 6 April 2014
  • ...[bioequivalence|bioequivalent]] to a [[brand]] name drug with respect to [[pharmacokinetics|pharmacokinetic]] and [[pharmacodynamics|pharmacodynamic]] properties. [[Va
    18 KB (2,553 words) - 13:17, 2 February 2023
  • ...=Heiskanen T, Olkkola KT, Kalso E| title=Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. | journal=Clin Pharmacol Ther | year= 19
    22 KB (2,960 words) - 17:35, 10 February 2024
  • ...pmid8968655">{{cite journal| author=Davies G, Kingswood C, Street M| title=Pharmacokinetics of opioids in renal dysfunction. | journal=Clin Pharmacokinet | year= 1996 ...nd metabolized by [[cytochrome P-450 CYP2D6]] which may lead to variable [[pharmacokinetics]] due to [[single-nucleotide polymorphism]]s and [[drug interaction]]s.<ref
    42 KB (5,794 words) - 14:08, 2 February 2023
  • ...="pmid8623000">{{cite journal |author=Levine M ''et al.'' |title=Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance |journa === Based on pharmacokinetics ===
    87 KB (12,868 words) - 00:29, 15 September 2013
  • ...cite journal |author=Zineh I, Beitelshees AL, Gaedigk A, ''et al.'' |title=Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy i
    36 KB (4,786 words) - 23:10, 12 October 2011
  • * [[Pharmacokinetics]]
    26 KB (3,398 words) - 05:06, 8 March 2024
  • ...penetration of one or both fangs from the snake, amount of venom injected, pharmacokinetics of the venom, location of the bite, and proximity to major blood vessels. T
    38 KB (5,884 words) - 14:21, 8 March 2024
  • ...w-resolution approaches. Improved information of drug logistics and target pharmacokinetics enables effective drug selection, dose determination and prediction. It als
    44 KB (6,407 words) - 15:57, 24 June 2015